Priftin Tablet, Film Coated
Product Images NDC 0088-2102

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Priftin (NDC 0088-2102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Priftin 01)

Chemical structure of rifapentine, the active ingredient in Priftin tablets. The diagram displays the molecular arrangement, including ring structures and various functional groups characteristic of rifapentine.*

FDA Label Image

Principal Display Panel (150 mg Tablet Blister Pack)

Packaging label for Priftin rifapentine 150 mg film-coated tablets by sanofi-aventis U.S. LLC. The carton contains 24 tablets arranged in three 8-tablet blister strips. The label includes directions to dispense with a medication guide and presents handling instructions for tablet removal from blister packs.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.